Stocks Health care PRVA
NASDAQ · Health carePrivia Health Group, Inc. (PRVA)
Privia Health Group, Inc. brought in $2.4B of revenue over the twelve months to September 30, 2026, up 19.2% from a year earlier. Net income was $34.8M, a net margin of 1.4%. At September 30, 2026 it held $446.3M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.
Key facts about Privia Health Group, Inc.
- Net worth
- Privia Health Group, Inc. has a market value (market cap) of $3.1B at the latest share price, and shareholders' equity of $815.7M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $2.1B (+22.3% year on year), with net income of $22.9M. Over the 12 months to September 30, 2026: revenue $2.4B, net income $34.8M.
- Cash flow
- In fiscal 2025 operations brought in $163.4M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Privia Health Group, Inc.'s next report is expected around February 25, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Privia Health Group, Inc. does
Privia Health Group, Inc. is registered with the SEC under industry code SIC 8000 (Services-Health Services). Its shares trade on NASDAQ under the ticker PRVA.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $2.1B | $22.9M | $0.18 | n/a |
| 2024 | $1.7B | $14.4M | $0.11 | n/a |
| 2023 | $1.7B | $23.1M | $0.19 | $80.7M |
| 2022 | $1.4B | -$8.6M | -$0.08 | $47.1M |
| 2021 | $966.2M | -$188.2M | -$1.83 | $54.5M |
| 2021 | $817.1M | $31.2M | $0.33 | $38.5M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where PRVA ranks in Health care
Latest SEC filings
What Privia Health Group, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 13% to $657M versus the same quarter last year; diluted EPS $0.10 versus $0.05.
- November 5, 2026
- October 30, 2026Passive stake (5% or more) SCHEDULE 13G
- October 7, 2026Passive stake changed SCHEDULE 13G/A
- September 8, 2026Activist stake (5% or more) SCHEDULE 13D
- August 18, 2026
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 21% to $632.6M versus the same quarter last year; diluted EPS $0.07 versus $0.02.
- August 6, 2026
- July 29, 2026Passive stake changed SCHEDULE 13G/A
- July 7, 2026
Insider trades
What the people running Privia Health Group, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 1 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 1, 2026 | Ernest Opella FinleyDirector | Received as pay | 6,350 | - |
| July 9, 2026 | Mountcastle DavidEVP & Chief Financial Officer | Soldpre-planned (10b5-1) | 21,275 | $588.7K |
| July 7, 2026 | Mountcastle DavidEVP & Chief Financial Officer | Soldpre-planned (10b5-1) | 600 | $16.5K |
| July 6, 2026 | Morris Matthew ShawnDirector | Exercised options | 53,722 | $107.4K |
| July 6, 2026 | Morris Matthew ShawnDirector | Soldpre-planned (10b5-1) | 53,722 | $1.5M |
| July 2, 2026 | Morris Matthew ShawnDirector | Exercised options | 59,037 | $118.1K |
| July 2, 2026 | Morris Matthew ShawnDirector | Soldpre-planned (10b5-1) | 59,037 | $1.6M |
| July 2, 2026 | Mountcastle DavidEVP & Chief Financial Officer | Soldpre-planned (10b5-1) | 24,734 | $680.2K |
Who owns PRVA
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Fmr LLC13G, passive with 1 related filers | 10.1% | November 5, 2025 |
| Durable Capital Partners LP13G, passive | 9.3% | November 14, 2024 |
| Vanguard Portfolio Management13G, passive | 5.16% | April 29, 2026 |
| Vanguard Capital Management13G, passive | 5.09% | October 30, 2026 |
| Puma Growth Holdings, LLC13D, may seek influence with 4 related filers | 5.07% | September 8, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 301 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 21,402,417 | +2,344,507 |
| Fmr LLC | 12,848,437 | -197,105 |
| Durable Capital Partners LP | 11,635,948 | -451,895 |
| Vanguard Portfolio Management LLC | 6,572,384 | +290,842 |
| Rubicon Founders LLC | 5,971,079 | +22,415 |
| Vanguard Capital Management LLC | 5,156,720 | +147,897 |
| State Street Corp | 4,905,789 | +415,889 |
| Geode Capital Management, LLC | 3,130,473 | +234,939 |
| Riverbridge Partners LLC | 2,998,597 | -919,351 |
| Bank of New York Mellon Corp | 2,892,536 | -50,957 |
| Principal Financial Group Inc | 2,587,878 | -135,195 |
| Dimensional Fund Advisors LP | 2,551,861 | +145,144 |
| Wellington Management Group Llp | 2,130,289 | +1,906,187 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1,948,021 | -103,638 |
| BlackBarn Capital Partners LP | 1,585,000 | 0 |
| Nuveen, LLC | 1,465,145 | +517,009 |
| Bank of America Corp | 1,432,117 | +175,939 |
| Charles Schwab Investment Management Inc | 1,374,828 | +55,722 |
| Goldman Sachs Group Inc | 1,302,019 | -37,931 |
| Northern Trust Corp | 1,253,501 | +75,791 |
Insiders
12 insiders reported holding 1,013,175 shares in total, about $24.9M at the last price.
| Holder | Shares |
|---|---|
| Mehrotra ParthChief Executive Officer, Director | 434,357 |
| Mountcastle DavidEVP & Chief Financial Officer | 164,853 |
| Fargis Edward CEVP & General Counsel | 111,979 |
| Morris Matthew ShawnDirector | 68,188 |
| King David PDirector | 50,775 |
| Ryu JaewonDirector | 47,110 |
| Cocozza Nancy GDirector | 42,814 |
| Kimmet Pamela ODirector | 34,172 |
| McCarthy Thomas ADirector | 27,983 |
| Berberian LanceDirector | 16,131 |
Questions about PRVA
What does Privia Health Group, Inc. do?
Privia Health Group, Inc. is a company in the Health care sector, listed on NASDAQ as PRVA. Its shares trade on NASDAQ under the ticker PRVA.
What is Privia Health Group, Inc.'s net worth?
Privia Health Group, Inc. has a market value (market cap) of $3.1B at the latest share price, and shareholders' equity of $815.7M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Privia Health Group, Inc. profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $34.8M on revenue of $2.4B, a net margin of 1.4%.
How much revenue does Privia Health Group, Inc. make?
Over the twelve months to September 30, 2026 Privia Health Group, Inc. reported revenue of $2.4B. That is 19.2% more than a year earlier.
When did Privia Health Group, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026.
When is Privia Health Group, Inc.'s next earnings report?
Privia Health Group, Inc.'s next report is expected around February 25, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare PRVA with
Follow PRVA
Get an email when Privia Health Group, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Privia Health Group, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.